 MT1 and MT2 receptors may be a target for the treatment of circadian and non circadian sleep disorders because of their differences in pharmacology and function within the SCN.The SCN is responsible for maintaining the 24 hour cycle which regulates many different body functions ranging from sleep to immune functions.Melatonin receptors have been identified in the cardiovascular system.